The latest report by IMARC Group, titled “Ureteral Stents Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global ureteral stents market size reached US$ 353.4 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 504.1 Million by 2028, exhibiting a growth rate (CAGR) of 6.2% during 2023-2028.

Ureteral stents are crucial medical devices designed to address a range of urinary tract issues. These slender, flexible tubes, often composed of materials like silicone or polyurethane, are inserted into the ureter, the duct that connects the kidneys to the bladder. Their primary function is to facilitate the flow of urine from the kidneys to the bladder, circumventing any obstructions or blockages. Ureteral stents play a pivotal role in alleviating urinary obstructions caused by conditions such as kidney stones, tumors, or strictures, as well as post-surgical complications. These stents are available in various sizes and designs to suit individual patient needs and the specific nature of their urinary tract conditions.

For an in-depth analysis, you can refer sample copy of the report:

Ureteral Stents Market Trends and Drivers:

One of the primary drivers of the global ureteral stents market is the rising incidence of urinary tract disorders worldwide. Factors such as dietary changes, sedentary lifestyles, and an aging population contribute to an increased prevalence of conditions like kidney stones and urinary strictures. As these conditions become more widespread, the demand for ureteral stents as a viable solution to relieve urinary obstructions continues to surge. In addition, the ureteral stents market has witnessed significant advancements in stent technology, which has positively impacted patient outcomes and market growth. Innovations in materials, design, and coatings have led to stents that offer improved biocompatibility, reduced encrustation, and decreased patient discomfort. Besides, the trend toward minimally invasive medical procedures is another driving force behind the growth of the ureteral stents market. Patients increasingly prefer procedures that involve smaller incisions, shorter recovery times, and reduced post-operative pain. Urologists and healthcare facilities offering minimally invasive options, including ureteral stent placement, are likely to attract more patients. Businesses in this sector should consider aligning their offerings with this trend by developing stents that are easier to insert and cause minimal discomfort to patients. Moreover, the global demographic shift toward an aging population plays a significant role in the ureteral stents market’s expansion. Elderly individuals are more susceptible to urinary tract issues and may require ureteral stents to manage these conditions.

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Product Type:

  • Open End Stents
  • Closed End Stents
  • Double J-Stent
  • Multiloop Stents

Breakup by Material:

  • Metallic Ureteral Stents
  • Polymer Ureteral Stents
    • Silicone Stents
    • Polyurethane Stents
    • Hybrid Stents

Breakup by Application:

  • Kidney Stones
  • Kidney Transplantation
  • Tumors
  • Urinary Incontinence
  • Others

Breakup by End Use:

  • Hospitals and Clinics
  • Ambulatory Surgical Centers (ASCs)
  • Others

Market Breakup by Region:

  • North America (United States, Canada)
  • Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
  • Latin America (Brazil, Mexico, Others)
  • Middle East and Africa

Competitive Landscape with Key Player:

  • Allium Medical Solutions Ltd.
  • B. Braun Melsungen AG
  • Biomerics
  • Boston Scientific Corporation
  • Becton
  • Dickinson and Company
  • Coloplast Ltd.
  • Cook Group Incorporated
  • Medline Industries Inc.
  • Merit Medical Systems Inc.
  • Olympus Corporation
  • Teleflex Incorporated.

Explore full report with table of contents:

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US



USA: +1-631-791-1145 | Asia: +91-120-433-0800

Address: 134 N 4th St. Brooklyn, NY 11249, USA

Follow us on Twitter: @imarcglobal

Comments (0)
No login
Login or register to post your comment